Dr. Yaw Bediako Joins Ashesi as Dean of Research and Innovation
Ashesi University is pleased to welcome Dr. Yaw Bediako as the Dean of Research and Innovation. In this role, he will provide strategic leadership to advance our research initiatives, foster innovation across various academic disciplines, and strengthen partnerships that support Ashesi’s mission. The Dean of Research and Innovation role highlights Ashesi’s commitment to deepening research […]
Bio Usawa and Yemaachi Biotech Unite to Transform HealthCare in Africa.
Diasporan biotech innovators co-develop monoclonal antibodies and genomic-driven solutions tailored for African patients. Kigali, Rwanda and Accra, Ghana — In a landmark collaboration, Bio Usawa, a pioneering biotechnology company building Africa’s monoclonal antibody development and manufacturing capacity, and Yemaachi Biotech, a leader in African cancer genomics, have joined forces to accelerate precision medicine and pharmacogenomics […]
Bloomberg New Economy Introduces the 2025 Class of Catalysts: Innovators Shaping a more Resilient, Inclusive Global Future.
Join our nine innovators, visionaries, scientists, and entrepreneurs — from Europe, Africa, Asia and North America — at this November’s Bloomberg New Economy Forum New York — October 20, 2025 — Bloomberg New Economy and Bloomberg Businessweek, today announced the 2025 Bloomberg New Economy Catalysts — a global community of entrepreneurs, scientists, policymakers, and visionaries driving transformative solutions […]
Building Biotechnology in Africa
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Precision Medicine on a Budget in Africa: using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs.
Alexandra Lindsey Djomkam Zune , Charles Ochieng’ Olwal, Emmanuel Agbeli , Abdoulaye Baniré Diallo , Emmanuella Amoako, Yaw Bediako , Lily Paemka. Abstract Variations in drug-metabolizing enzymes and transporters are associated with adverse drug reactions (ADRs). ADRs to cancer drugs can differ among populations owing to environmental and genetic differences. Due to limited resources and prohibitive costs associated with drug development, African countries rely on […]
Yemaachi Biotech and Illumina Announce the Arrival of the NovaSeq X Plus in Ghana
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
A Bold Step into Building Africa’s Cancer Atlas.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.
Tackling Bias in Health- BBC World Service.
At Yemaachi, Bediako is developing cancer diagnostics and treatments tailored to Africans, and he describes the limited official data on patients with cancer across Africa as a major challenge.